Fortrea Holdings Inc.

US$21.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:FTREHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (12.21%)
Div yield —
ROE (12.34%)
Biotechnology
Beta (5Y) 1.86
PE TTM —
TSR TTM 109.94%
Mkt cap US$2.119B
ROIC 3.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$25
12.72%
(96.28%)
Hold 1|10|4|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.24
0.24
0.27
30.91%
17.20%
10.77%
13.39%
Revenue$M
140.7
144.9
143.3
143.2
5.51%
10.91%
4.68%
6.64%
Peers (US$2.119B)
Cap (US$)
PE
2.103B
—
2.112B
90.48x
Capital
TTM
5Y
10Y
Leveragex
0.971
0.194
0.185
EBIT/Intx
0.855
0.420
0.330
Own earn%
60.69
(10.65)
(14.28)
Sh yield%
34.49
37.97
35.87
Owners
Insiders/Inst%
1.02
80.88
Short interest%
3.28
SBC / revenue%
3.55
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
9–14
$1 testx
—
Incr. ROIC%
3